MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 36 filers reported holding MYOVANT SCIENCES LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,547,908 | +230.0% | 57,415 | +119.8% | 0.00% | – |
Q3 2022 | $469,000 | +43.4% | 26,121 | -0.6% | 0.00% | – |
Q2 2022 | $327,000 | -7.6% | 26,276 | -1.2% | 0.00% | – |
Q1 2022 | $354,000 | -14.5% | 26,583 | 0.0% | 0.00% | – |
Q4 2021 | $414,000 | -30.7% | 26,583 | 0.0% | 0.00% | – |
Q3 2021 | $597,000 | +20.4% | 26,583 | +22.0% | 0.00% | – |
Q2 2021 | $496,000 | -41.4% | 21,783 | -47.0% | 0.00% | – |
Q1 2021 | $846,000 | +27.2% | 41,125 | +70.7% | 0.00% | – |
Q4 2020 | $665,000 | +101.5% | 24,094 | +2.6% | 0.00% | – |
Q3 2020 | $330,000 | -46.7% | 23,479 | -21.8% | 0.00% | – |
Q2 2020 | $619,000 | +172.7% | 30,040 | -0.0% | 0.00% | – |
Q1 2020 | $227,000 | -51.3% | 30,041 | +0.0% | 0.00% | – |
Q4 2019 | $466,000 | -79.0% | 30,040 | -93.0% | 0.00% | -100.0% |
Q3 2019 | $2,224,000 | -40.0% | 427,557 | +4.4% | 0.00% | 0.0% |
Q2 2019 | $3,706,000 | -62.7% | 409,507 | -1.7% | 0.00% | -66.7% |
Q1 2019 | $9,944,000 | +64.1% | 416,563 | +12.8% | 0.00% | +50.0% |
Q4 2018 | $6,060,000 | +1823.8% | 369,320 | +3012.4% | 0.00% | – |
Q3 2018 | $315,000 | +16.2% | 11,866 | 0.0% | 0.00% | – |
Q2 2018 | $271,000 | +7.5% | 11,866 | 0.0% | 0.00% | – |
Q1 2018 | $252,000 | +57.5% | 11,866 | -6.5% | 0.00% | – |
Q4 2017 | $160,000 | -13.0% | 12,686 | +6.9% | 0.00% | – |
Q3 2017 | $184,000 | +32.4% | 11,866 | 0.0% | 0.00% | – |
Q2 2017 | $139,000 | -50.2% | 11,866 | -50.1% | 0.00% | – |
Q1 2017 | $279,000 | +28.6% | 23,784 | +36.3% | 0.00% | – |
Q4 2016 | $217,000 | – | 17,454 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |